GridAI Technologies (GRDX) Payables (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Payables came in at $5.7 million in Q4 2025, up 34.57% YoY from $4.3 million in Q4 2024, and down 12.12% on a QoQ basis from $6.5 million in Q3 2025.
GridAI Technologies (GRDX) Payables (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Payables data on file, last reported at $5.7 million in Q4 2025.
- Quarterly Payables rose 34.57% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.7 million (up 34.57% YoY) and the FY2025 annual result came in at $5.7 million, up 34.57% from the prior year.
- Payables slipped to $5.7 million in Q4 2025, from $6.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $18.9 million in Q3 2021 to a low of $810338.0 in Q3 2023.
- A 5-year average of $4.1 million and a median of $3.6 million in 2021 frame the typical range for Payables.
- Annual changes were most pronounced in 2021 — Payables jumped 787.79% — and 2022, when it plunged 79.5%.
- Tracing GRDX's Payables over 5 years: stood at $3.8 million in 2021, then sank by 45.34% to $2.1 million in 2022, then rose by 7.27% to $2.2 million in 2023, then surged by 90.9% to $4.3 million in 2024, then jumped by 34.57% to $5.7 million in 2025.
- The last three Payables figures came in at $5.7 million (Q4 2025), $6.5 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 35.57 Mn |
| 10 | GridAI Technologies | 6.26 Mn | 6.26 Mn | - | 7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 3.46 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 4.27 Mn |
| Sep 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.45 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 810,338.00 |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 937,581.00 |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 3.94 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 18.93 Mn |
| Jun 30, 2021 | 5.01 Mn |
| Mar 31, 2021 | 2.26 Mn |